NVR 7P5 (Afinitor 7.5 mg)
Generic Name: everolimus
Pill with imprint NVR 7P5 is White, Elliptical / Oval and has been identified as Afinitor 7.5 mg. It is supplied by Novartis Pharmaceuticals.
Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR 7P5
Afinitor
- Generic Name
- everolimus
- Imprint
- NVR 7P5
- Strength
- 7.5 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Mtor inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0620
- Inactive Ingredients
-
butylated hydroxytoluene,
crospovidone,
hypromelloses,
lactose anhydrous,
lactose monohydrate,
magnesium stearate
Note: Inactive ingredients may vary.
More about Afinitor (everolimus)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 16 Reviews
- Generic Availability
- Drug class: mTOR inhibitors
- FDA Approval History
Consumer resources
- Other brands
- Zortress
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.